Influence of Melatonin-Correcting Drugs (Melaxen and Valdoxan) on the Levels of Superoxide Dismutase and Catalase Gene Transcription in Rats with Experimental Hyperthyroidism

T. N. Popova; A. A. Agarkov; M. V. Gorbenko; S. S. Popov; K. K. Shul’gin

doi:10.1007/s11094-016-1409-y

Influence of Melatonin-Correcting Drugs (Melaxen and Valdoxan) on the Levels of Superoxide Dismutase and Catalase Gene Transcription in Rats with Experimental Hyperthyroidism

Autores: Popova T.N.¹, Agarkov A.A.¹, Gorbenko M.V.¹, Popov S.S.², Shul’gin K.K.¹
Afiliações:
1. Voronezh State University
2. N. N. Burdenko Voronezh State Medical Academy
Edição: Volume 50, Nº 3 (2016)
Páginas: 127-130
Seção: Molecular-Biological Problems of Drug Design and Mechanism of Drug Action
URL: https://ogarev-online.ru/0091-150X/article/view/244330
DOI: https://doi.org/10.1007/s11094-016-1409-y
ID: 244330

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Sobre autores
Bibliografia
Arquivos suplementares
Estatísticas

Resumo

The influence of the melatonin-correcting drugs melaxen and Valdoxan on the gene-transcription level of superoxide dismutase (SOD, EC 1.15.1.1) and catalase (EC 1.11.1.6) in liver and heart of rats with hyperthyroidism has been investigated. Administration of these drugs to rats with model pathology leads to changes in SOD and catalase expression in their tissues toward the control values.